Charles River Introduces Its Vector Tech Transfer Program To Safeguard Gene Therapy Development
Charles River Introduces Its Vector Tech Transfer Program To Safeguard Gene Therapy Development
Fast Track and Modular frameworks facilitate product development continuity via seamless process transfer to the Company's viral vector Center of Excellence
快速通道和模塊式框架可通過無縫的流程轉移促進產品開發連續性，轉移到公司的病毒載體卓越中心
Charles River Laboratories International, Inc. (NYSE:CRL) today announced the introduction of its Modular and Fast Track viral vector technology (tech) transfer frameworks. Based on decades of viral vector contract development and manufacturing organization (CDMO) experience, the Company has designed a methodical program to drive successful, accelerated process transfer to its Maryland-based viral vector center of excellence (CoE) in as little as nine months.
Charles River實驗室國際公司（紐交所：CRL）今天宣佈推出其模塊化和快速通道病毒載體技術（tech）轉移框架。基於幾十年的病毒載體合同開發和製造組織（CDMO）經驗，該公司設計了一種系統的計劃，以在僅九個月內成功推進其位於馬里蘭州的病毒載體卓越中心（CoE）的加速過程轉移。
譯文內容由第三人軟體翻譯。